rs782568024
Your query was ambiguous. Multiple possible variants found:
- chr8-144051482-CGGGGGG-C
- chr8-144051482-CGGGGGG-CG
- chr8-144051482-CGGGGGG-CGG
- chr8-144051482-CGGGGGG-CGGG
- chr8-144051482-CGGGGGG-CGGGG
- chr8-144051482-CGGGGGG-CGGGGG
- chr8-144051482-CGGGGGG-CGGGGGGG
- chr8-144051482-CGGGGGG-CGGGGGGGG
- chr8-144051482-CGGGGGG-CGGGGGGGGG
- chr8-144051482-CGGGGGG-CGGGGGGGGGG
- chr8-144051482-CGGGGGG-CGGGGGGGGGGG
- chr8-144051482-CGGGGGG-CGGGGGGGGGGGG
- chr8-144051482-CGGGGGG-CGGGGGGGGGGGGG
- chr8-144051482-CGGGGGG-CGGGGGGGGGGGGGG
- chr8-144051482-CGGGGGG-CGGGGGGGGGGGGGGG
- chr8-144051482-CGGGGGG-CGGGGGGGGGGGGGGGG
- chr8-144051482-CGGGGGG-CGGGGGGGGGGGGGGGGG
- chr8-144051482-CGGGGGG-CGGGGGGGGGGGGGGGGGG
- chr8-144051482-CGGGGGG-CGGGGGGGGGGGGGGGGGGG
- chr8-144051482-CGGGGGG-CGGGGGGGGGGGGGGGGGGGG
- chr8-144051482-CGGGGGG-CGGGGGGGGGGGGGGGGGGGGG
- chr8-144051482-CGGGGGG-CGGGGGGGGGGGGGGTGGGGGGGGGGGG
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_017570.5(OPLAH):c.3721-16_3721-11delCCCCCC variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000389 in 257,080 control chromosomes in the GnomAD database, with no homozygous occurrence. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: not found (cov: 29)
Exomes 𝑓: 0.0000039 ( 0 hom. )
Consequence
OPLAH
NM_017570.5 intron
NM_017570.5 intron
Scores
Not classified
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.135
Genes affected
OPLAH (HGNC:8149): (5-oxoprolinase, ATP-hydrolysing) The protein encoded by this gene acts as a homodimer, using ATP hydrolysis to catalyze the conversion of 5-oxo-L-proline to L-glutamate. Defects in this gene are a cause of 5-oxoprolinase deficiency (OPLAHD). [provided by RefSeq, Jun 2012]
SMPD5 (HGNC:52275): (sphingomyelin phosphodiesterase 5 (pseudogene)) Predicted to enable sphingomyelin phosphodiesterase activity. Predicted to be involved in ceramide biosynthetic process and sphingomyelin catabolic process. Predicted to act upstream of or within ceramide metabolic process. Predicted to be located in endoplasmic reticulum membrane and mitochondrial membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 29
GnomAD3 genomes
Cov.:
29
GnomAD4 exome AF: 0.00000389 AC: 1AN: 257080Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 131886
GnomAD4 exome
AF:
AC:
1
AN:
257080
Hom.:
AF XY:
AC XY:
0
AN XY:
131886
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 29
GnomAD4 genome
Cov.:
29
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.